Your browser doesn't support javascript.
loading
[Harmonizing development, approval and access of drugs for rare diseases in Europe.] / Verso un modello integrato di sviluppo, approvazione e accesso dei farmaci per malattie rare in Europa.
Costa, Enrico; Magrini, Nicola.
Affiliation
  • Costa E; Settore Affari Internazionali, Agenzia Italiana del Farmaco, Roma; Committee for Orphan Medicinal Products (COMP), Agenzia Europea dei Medicinali (EMA), Amsterdam.
  • Magrini N; Direttore Generale, Agenzia Italiana del Farmaco, Roma.
Recenti Prog Med ; 113(7): 407-410, 2022.
Article in It | MEDLINE | ID: mdl-35852074
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Orphan Drug Production / Rare Diseases Limits: Humans Country/Region as subject: Europa Language: It Journal: Recenti Prog Med Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Orphan Drug Production / Rare Diseases Limits: Humans Country/Region as subject: Europa Language: It Journal: Recenti Prog Med Year: 2022 Document type: Article